J. H. Bordelon

Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancer.

F. Holmes, J. O’Shaughnessy, J. Pippen, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparison of menopausal symptoms during the first year of adjuvant therapy with either exemestane or tamoxifen in early breast cancer: report of a Tamoxifen Exemestane Adjuvant Multicenter trial substudy.

F. Holmes, J. O’Shaughnessy, J. Pippen, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735.

F. Holmes, J. O’Shaughnessy, J. Pippen, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.